AKR1B10 and metabolic dysfunction-associated steatotic liver disease: We identified three signature genes—HSD17B14, AKR1B10, and RGS4—with fold changes in expression similar to those observed in advanced stages of NAFLD in human patients in the female liver of the BPA lineage medaka[37].